Related Experiment Video
Updated: Jul 12, 2026

Measurement of Pulse Propagation Velocity, Distensibility and Strain in an Abdominal Aortic Aneurysm Mouse Model
Published on: February 23, 2020
The Role of miR-501-3p in Abdominal Aortic Aneurysm Progression: A Pilot Study
Hiroki Mine1, Kensuke Toyama2,3,4, Kenshi Yoshimura5
1Division of Cardiovascular Surgery, Department of Surgery, Kurume University School of Medicine, 67 Asahi, Kurume, Fukuoka, 830-0011, Japan.
Abstract:
MiR-501-3p, a small non-coding RNA, has been linked to vascular damage and arterial stiffness, but its role in abdominal aortic aneurysm (AAA) remains unknown. Blood exosomal microRNAs were extracted, and RNA was also extracted from tissue samples, including both the region of maximum aortic dilation and the transition zone between normal and aneurysmal tissue. The low blood miR-501-3p expression group included more AAA patients and greater size than the high group. Multivariate analysis revealed a significant association between the presence of AAA and low blood miR-501-3p (OR = 6.467, p < 0.05). In AAA tissue, miR-501-3p was lower in the maximum point compared to the border point and correlated with larger AAA sizes. All low expression cases at the maximum point had an AAA ≥ 55 mm, whereas only 9.5% of cases in the high expression group had an AAA ≥ 55 mm (P < 0.01). miR-501-3p was identified as a potential key indicator and regulator of AAA presence and expansion.
Insights
Low expression of microRNA-501-3p (miR-501-3p) is linked to abdominal aortic aneurysm (AAA) presence and expansion. This finding suggests miR-501-3p may serve as a key biomarker for AAA.
Area of Science:
- Cardiovascular Biology
- Molecular Biology
- Biomarker Discovery
Background:
- MicroRNA-501-3p (miR-501-3p) is implicated in vascular damage and arterial stiffness.
- The specific role of miR-501-3p in abdominal aortic aneurysm (AAA) pathogenesis is not well understood.
Purpose of the Study:
- To investigate the association between miR-501-3p expression levels and the presence and severity of AAA.
- To explore miR-501-3p as a potential diagnostic or prognostic biomarker for AAA.
Main Methods:
- Extraction of exosomal microRNAs from blood samples of patients.
- RNA extraction from abdominal aortic aneurysm tissue, including areas of maximum dilation and transition zones.
- Quantitative analysis of miR-501-3p expression and statistical correlation with AAA presence and size.
Main Results:
- Lower blood miR-501-3p expression was significantly associated with the presence of AAA (OR=6.467, p<0.05).
- AAA patients exhibited lower miR-501-3p levels in blood and tissue compared to controls.
- Reduced miR-501-3p expression in AAA tissue correlated with larger aneurysm size, with low expression linked to aneurysms ≥55 mm.
Conclusions:
- MicroRNA-501-3p expression is significantly reduced in patients with abdominal aortic aneurysm.
- Low miR-501-3p levels may indicate the presence and predict the expansion of AAA.
- miR-501-3p shows potential as a key regulator and biomarker for AAA.
Related Concept Videos
Aneurysm III: Interprofessional Care
Aneurysm I: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies

